Novartis AG Sponsored ADR is a company in the U.S. stock market and it is a holding in 12 U.S.-traded ETFs. NVS has around 3.4M shares in the U.S. ETF market. The largest ETF holder of NVS is the ARK Genomic Revolution ETF (ARKG), with approximately 2.18M shares. Investors may also find of interest that the ETF with the largest allocation to NVS stock is VanEck Vectors Pharmaceutical ETF (PPH), with a portfolio weight of 4.85%. On average, U.S. ETFs allocate 1.68% of NVS to their portfolios.
Additionally, NVS is a favorite stock for Active and Dividends ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with NVS as a holding is the SPDR S&P Kensho New Economies Composite ETF (KOMP), with a return of 54.60%.